A Look at Elysium Health’s First Supplement

For the numerous people interested in improving their health in the new year, now is a great time to invest your time to look into the area of personal well-being.

Elysium Health is a health startup producing evidence-based dietary supplements. Since 2014, the company has invested its time and effort to create an affordable and effective product to improve people’s cellular health.

Although some supplements have the potential to improve personal health, anyone looking to transform their health also needs to improve their daily habits in addition to consuming supplements.


Elysium Health has created a supplement called Basis. Basis helps people support their cellular health by increasing levels of NAD+ in our cells. NAD+ is a coenzyme that is essential to many cellular functions like circadian rhythms, energy creation, and DNA maintenance. As we age, levels of NAD+ naturally decline, but Basis works to raise and maintain higher levels of the coenzyme.

One of the best things about Basis is that it is affordable to take. Elysium Health will send you a bottle of Basis once a month for between $40 and $60 depending on the length of your subscription. For more information about Basis, other products Elysium Health is in the process of developing , or the team of researchers working with the company, visit Elysium Health’s website.

M1ND from Jeunesse Global Product Review

Jeunesse Global has produced a number of great products for their customers to enjoy over the years. One product that we can all appreciate is a little something called “M1ND”. Yes, it is spelled just like that.

M1ND is a dietary supplement that comes in an attractive little yellow pouch that makes it easy to carry around and easy to consume when you are ready to do so. Its purpose is to enhance the functions that your mind is able to do. Basically, the things that most of us worry we will not be able to do as we age, this supplement helps us to ensure that actually we still can. If you are interested in protecting your mind against decline, then you need to start making proactive steps to protect it. One of those steps might be to start using M1ND.

The flavor for a powerful supplement like this might not taste so great with other suppliers, but that is not the case with Jeunesse Global. They put out their variety with a nice lemon twist to it. You can enjoy the flavor and not have to worry about sipping down something that tastes terrible. Instead, you can enjoy your daily supplement and get all of your benefits from it right away.

The nice thing about this product from Jeunesse Global is that it is good for both a quick mental boost, and also for a more sustained period of improved mental health. No matter your purposes for taking it, you can get something out of it right way. As such, you can probably stick to taking this supplement perhaps better than you would with some others.

The company itself has been proud to launch M1ND along with a variety of other products that make up its Youth Enhancement System (Y.E.S.) to customers all around the world. Even though they are less than ten years old, the company has already made a global footprint. Expansion is in the works every year, and the number of people who make money from their success continues to grow as well with each passing year.

Retired CEO of UTC, Louis Chenevert, Designs His Own Yacht

Louis Chenevert was once CEO of United Technologies and helped to make it a global company. During his time with the company it invested over $10 billion in designing and manufacturing a jet engine that reduced fuel consumption and reduced emissions.

This engine is used in over 14 airlines in their jets. His interest in investing in technology is what led to success with designing this jet engine. When he worked on this project, he did not focus on the gains the company would make. He pictured a distant future where the company would grow and hire thousands of employees to make the products they designed.

He worked for over 14 years for General Motors. Louis Chenevert was made president of UTC after only six years and received an award from the National Building Museum in 2011. He was named Person of the Year by Aviation Week and Space Technology Magazine.

His goal was to unite the manufacturing and suppliers. This leading to UTC’s success.

Looking at more than one aspect of the business helped to increase their customer base. He encouraged the company to invest in their employees with programs like The Employee Scholar Program. It helped employees earn a degree in any subject they chose. UTC paid for the tuition. This are the many benefits Louis Chenevert brought UTC when he worked there.

Now he designs yachts another passion he has. He has build three yachts with the help of Horizon a yacht builder. The yachts are loaded with technology a feature that Louis Chenevert loves. To assemble the yacht he traveled to the company’s location in Taiwan. This yacht is called the Debbie Lou.

The Debbie Lou has technology that would be seen in larger yachts because that is the way they are designed. Since he planned to sail with his family and friends he had the best and safest yacht designed.

It has two radar system, AIS and night vision. The yacht has satellite receivers for TV and phone communication from anywhere. The yacht has GPS and pilot system monitor. He has plans to keep it for several years.

How Robert Ivy Is Leading The Architecture Industry

Robert Ivy has been described as a soft-spoken man who is warm and wise. He is the executive vice president and chief executive officer fo the American Institute of Architects (AIA). This is a professional organization that supports architects and those in related positions. He has said that one way he can help the profession is by encouraging architects to work with software programmers so that they can exchange information. This will lead to better city planning in the United States.

Architecture can help in all sorts of ways people haven’t considered, Robert Ivy has said. It affects everything from improving a communities health to figuring out the best disaster relief solution. His organization has recently committed to a 10-year plan that is focused on improving urban areas. This includes sustainability, resiliency to natural disasters (such as hurricanes), and public health. The AIA is doing this by providing grants to university research projects. They are also developing a community plan with a major international city that they haven’t revealed as of yet.

Robert Ivy points out that architecture has long played a role in improving health. It was an architect who drained the swamps so that Washington D.C. could be built, he says. An architect also designed Central Park in New York City which was done to eliminate a problem they had with substandard housing in the area. The primary reason Central Park was built, he says, was to improve public health. That it’s now thought of as a recreation space wasn’t the reason it was actually built.

The AIA is based in Washington D.C. It was established in 1857 in New York City and soon chapters of this organization popped up around the United States. It now has over 300 chapters and close to 100,000 members. The members of this organization pledge to follow a code of professional conduct and ethics when performing their jobs. This is done so that their clients and people in general know that the architect they are working with is held to the highest professional standards.

For several years Robert Ivy was the Editor in Chief of the distinguished industry magazine Architectural Record. His leadership of this magazine led to it being the most widely read architectural magazine on the planet. He worked as an architect from 1981 to 1996 at a firm he started with business partners called Dean/Dale, Dean & Ivy.

At the AIA, Richard Ivy is working to transform the organization in how it helps those in the industry. It is now taking a proactive and responsive approach to issues, for example. They are helping those in this profession by raising public awareness of how important architects are in their daily lives.

Read this article:http://www.zdnet.com/article/qa-robert-ivy-ceo-the-american-institute-of-architects/


The Incredible Career and Life of Scott Rocklage

Attending college and being awarded a degree is a common thing. However, applying one’s education in real life to stand out from others is a great achievement.

Against all odds, Dr. Scott Rocklage studied hard to receive his B.S in chemistry, and he never gave up until he completed his Ph.D. studies in the same. The two academic qualifications were received from the University of California and the Massachusetts Institute of Technology respectively.  Learn more about Scott Rocklage: http://chemistry.mit.edu/scott-rocklage-phd-2-and-his-wife-patty-are-celebrated-their-major-gift and http://people.equilar.com/bio/scott-rocklage-cidara-therapeutics-/salary/913398#.WWaMA9PytTY

Although most people study chemistry to be awarded a degree so as to secure better jobs, this course was a passion for Dr. Scott Rocklage. This can be depicted by relentless efforts and hard work that made him receive the Nobel Prize in Chemistry back in 2005.

Today, he is acknowledged for being an inventor or a co-inventor on more than 30 U.S. patents. Besides, peer-reviewed publications that relate to him are not less than 100. Presently, people willing to meet him can book appointments in Boston, MA office.

Scott M. Rocklage, Ph.D. has provided his services in a number of companies. Most notably, in 2003, he became of the staff members of 5AM Ventures as a distinguished Venture Partner. Based on his qualifications and input, he surprisingly climbed the ladder to becoming a Managing partner in 2004, after only a year of experience with this company.

That said, it is important to note that Scott Rocklage has over 30 years of experience in the field of healthcare management. Some of his notable achievements include the successful approval of 3 different U.S. New Drug Applications by the FDA.

Other than 5AM Ventures, Dr. Rocklage has served as the chairman as well as the CEO of Cubist Pharmaceuticals. Additionally, he held the same senior positions in Nycomed Salutor, and he has also been a manager at Salutar and Catalytica.

At the moment, Dr. Scott Rocklage serves as a Board Chairman of various companies including Kinestral, Rennovia, and Cidara. He was able to secure these positions due to his past positions in Ilypsa which was acquired by Amgen, and Miikana which was as well acquired by EntreMed.